Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

B7

The B7 family constitutes a pivotal group of co-signaling molecules in immune regulation, encompassing members such as B7-1 (CD80), B7-2 (CD86), B7-H1 (PD-L1), B7-DC (PD-L2), B7-H3 (CD276), B7-H4 (VTCN1), B7-H5 (HHLA2), B7-H6, and B7-H7. These molecules mediate activation or inhibitory signals by binding to CD28/CTLA-4, PD-1, or undefined receptors, thereby regulating T cell activation, proliferation, and immune tolerance. The B7 family plays a critical role in infection, autoimmunity, and tumor immune evasion, and has emerged as a significant therapeutic target for immune checkpoint inhibitors, CAR-T therapies, and bispecific antibodies.

Puxitatug
T813452760250-47-1
Puxitatug (INT-016) is a humanised monoclonal antibody targeting VTCN1 B7H4, commonly used as the targeting component of the antibody-drug conjugate (ADC) Puxitatug samrotecan, delivering the drug specifically to cancer cells expressing B7-H4.
  • $247
In Stock
Size
QTY